HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].

Abstract
Antinuclear antibodies (ANA) of the IgG class were detected in 60% of patients with dermatomyositis. Only in 16% could we demonstrate precipitating antibodies against the nuclear Mi-2 antigen. These antibodies are considered to be serological markers of dermatomyositis. The ANA spectrum in polymyositis-overlap syndrome was considerably more heterogeneous: patients with polymyositis/progressive systemic scleroderma overlap had antibodies against the nucleolar PM-Scl antigen or the nuclear Ku antigen. Cytoplasmic antibodies to Jo-1 were present in polymyositis associated with Sjögren's syndrome and pulmonary fibrosis. Antibodies against ribosomal ribonucleoprotein were found in polymyositis with systemic lupus erythematosus and antibodies to nuclear ribonucleoprotein in polymyositis associated with mixed connective tissue disease. The investigation demonstrates that the characterization of ANA specificities helps to differentiate between dermatomyositis and distinct forms of polymyositis-overlap syndrome.
AuthorsM Meurer, G Hausmann-Martinez-Pardo, O Braun-Falco
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 40 Issue 10 Pg. 623-9 (Oct 1989) ISSN: 0017-8470 [Print] Germany
Vernacular TitleDas Spektrum antinukleärer und antizytoplasmatischer Antikörper bei Dermatomyositis und Polymyositis-Overlap-Syndromen.
PMID2482267 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • Autoantibodies
  • RNA
Topics
  • Adult
  • Aged
  • Antibodies, Antinuclear (analysis)
  • Autoantibodies (analysis)
  • Cytoplasm (immunology)
  • Dermatomyositis (immunology)
  • Female
  • Humans
  • Immunologic Techniques
  • Lupus Erythematosus, Systemic (immunology)
  • Male
  • Middle Aged
  • Myositis (immunology)
  • RNA (immunology)
  • Scleroderma, Systemic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: